Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immunovant Inc

IMVT
Current price
15.15 USD +0.31 USD (+2.09%)
Last closed 14.39 USD
ISIN US45258J1025
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 2 573 393 920 USD
Yield for 12 month -47.29 %
1Y
3Y
5Y
10Y
15Y
IMVT
21.11.2021 - 28.11.2021

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, Graves diseases, and warm autoimmune hemolytic anemia. Immunovant, Inc. is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. Address: 320 West 37th Street, New York, NY, United States, 10018

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

46.77 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-231 000 USD

Last Year

-1 324 000 USD

Current Quarter

Last Quarter

Key Figures IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -404 873 984 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -44.73 %
PEG Ratio
Return On Equity TTM -74.17 %
Wall Street Target Price 46.77 USD
Revenue TTM
Book Value 2.40 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.62 USD
Diluted Eps TTM -2.62 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMVT

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -14.12
Price Book MRQ 7.30

Financials IMVT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMVT

For 52 weeks

12.72 USD 34.47 USD
50 Day MA 18.37 USD
Shares Short Prior Month 15 799 702
200 Day MA 25.63 USD
Short Ratio 10.43
Shares Short 19 685 000
Short Percent 22.50 %